High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
|Articles|June 4, 2020
- The Column-06-04-2020
- Volume 16
- Issue 6
Vol 16 No 6 The Column June 2020 Europe and Asia PDF
Click the title above to open The Column June 2020 Europe & Asia issue, Volume 16, Number 6, in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Vol 16 No 6 The Column June 2020 North American PDFover 6 years ago
Chromatography in the time of COVID-19over 6 years ago
Detecting Equine Antipsychotic Drug Abuseover 6 years ago
Agilent Award LabCentral Golden Ticket to Trilogy Sciencesover 6 years ago
Microfluidic Lab-on-a-Chip Devices for Analytical ChemistryAdvertisement
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
4
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
5